Rowland Illing

Chief Medical Officer & Director, Healthcare & Life Sciences Amazon Web Services (AWS)

Dr. Rowland Illing serves as Chief Medical Officer and Director of Healthcare and Life Sciences for Amazon Web Services (AWS). His work centers on enabling customers to leverage core cloud technology and innovation, such as generative artificial intelligence, agents, robotics and quantum computing to drive better data utilization for improved efficiency, research and patient outcomes. He also works directly with teams internal to AWS on which technologies can be built and scaled most effectively to support healthcare and life science customers globally.

An Academic Interventional Radiologist by training, Dr. Illing was previously Director of the Interventional Oncology Service at University College Hospitals London. He holds positions as Honorary Associate Professor at University College London and Visiting Professor of Informatics and Imaging at Oxford University. His professional affiliations include membership of the Royal College of Surgeons of England, fellowships of the Royal College of Radiologists and Royal Society of Medicine, and senior fellowship of the UK’s Faculty of Medical Leadership and Management. He represents both Amazon and AWS in the Leadership Consortium of the US National Academy of Medicine, and is a member of the Board of Directors of HIMSS Global. Dr. Illing maintains an active presence in academia through ongoing presentations and publications in the field.

Seminars

Wednesday 7th October 2026
The Multimodal Imperative: Scaling Precision with AI-Integrated Data
10:00 am
  • What’s Possible: Uncovering the lost signals in today’s disjoined multimodal data landscape
  • Key Consideration: Building an AI-ready data foundation for multimodal data, designed to address security, compliance, and scalability requirements, while enabling federated governance so data remains sovereign and cross-institutional insight remains possible
  • The AI Layer: How a connected multimodal foundation improves the ability to answer complex cross-domain questions, democratizes access for all users, and shortens the path from molecular insight to clinical decision
Rowland_Illings[1]